These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 34625366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A, Liver-HERO Study Group.
    Trials; 2023 Apr 05; 24(1):258. PubMed ID: 37020315
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
    Hamel B, Guillaud O, Roman S, Vallin M, Pilleul F, Valette PJ, Henry L, Guibal A, Mion F, Dumortier J.
    Dig Liver Dis; 2014 Nov 05; 46(11):1001-7. PubMed ID: 25096966
    [Abstract] [Full Text] [Related]

  • 8. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G.
    Am J Gastroenterol; 1999 May 05; 94(5):1361-5. PubMed ID: 10235219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure.
    Michl P, Gülberg V, Bilzer M, Waggershauser T, Reiser M, Gerbes AL.
    Scand J Gastroenterol; 2000 Jun 05; 35(6):654-8. PubMed ID: 10912668
    [Abstract] [Full Text] [Related]

  • 11. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M, Hanouneh M, S Ascha M, Zein NN, Sands M, Lopez R, Hanouneh IA.
    Dig Dis Sci; 2017 Feb 05; 62(2):534-542. PubMed ID: 27154510
    [Abstract] [Full Text] [Related]

  • 12. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH.
    World J Gastroenterol; 2014 Mar 14; 20(10):2704-14. PubMed ID: 24627607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.
    Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T.
    Gut; 2000 Aug 14; 47(2):288-95. PubMed ID: 10896924
    [Abstract] [Full Text] [Related]

  • 15. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.
    Blendis L, Wong F.
    Clin Med (Lond); 2003 Aug 14; 3(2):154-9. PubMed ID: 12737373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of refractory ascites and hepatorenal syndrome.
    Chutaputti A.
    J Gastroenterol Hepatol; 2002 Apr 14; 17(4):456-61. PubMed ID: 11982727
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatorenal syndrome.
    Bataller R, Ginès P, Arroyo V, Rodés J.
    Clin Liver Dis; 2000 May 14; 4(2):487-507. PubMed ID: 11232202
    [Abstract] [Full Text] [Related]

  • 20. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P.
    Eur J Gastroenterol Hepatol; 2019 May 14; 31(5):626-632. PubMed ID: 30550458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.